Your browser doesn't support javascript.
loading
THADA drives Golgi residency and upregulation of PD-L1 in cancer cells and provides promising target for immunotherapy.
Li, Chushu; Chi, Hao; Deng, Shouyan; Wang, Huanbin; Yao, Han; Wang, Yungang; Chen, Dawei; Guo, Xun; Fang, Jing-Yuan; He, Fang; Xu, Jie.
Afiliación
  • Li C; Zhongshan-Xuhui Hospital, Institutes of Biomedical Sciences (visiting), Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism (Ministry of Science and Technology), Fudan University, Shanghai, China.
  • Chi H; Division of Gastroenterology and Hepatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Deng S; Zhongshan-Xuhui Hospital, Shanghai Xuhui Central Hospital, Institutes of Biomedical Sciences, Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism (Ministry of Science and Technology), Fudan University, Shanghai, China.
  • Wang H; Zhongshan-Xuhui Hospital, Institutes of Biomedical Sciences (visiting), Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism (Ministry of Science and Technology), Fudan University, Shanghai, China.
  • Yao H; Division of Gastroenterology and Hepatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Wang Y; Zhongshan-Xuhui Hospital, Institutes of Biomedical Sciences (visiting), Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism (Ministry of Science and Technology), Fudan University, Shanghai, China.
  • Chen D; Division of Gastroenterology and Hepatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Guo X; Zhongshan-Xuhui Hospital, Shanghai Xuhui Central Hospital, Institutes of Biomedical Sciences, Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism (Ministry of Science and Technology), Fudan University, Shanghai, China.
  • Fang JY; Innomodels Biotechnology (Beijing) Co., Ltd, Beijing, China.
  • He F; Innomodels Biotechnology (Beijing) Co., Ltd, Beijing, China.
  • Xu J; Division of Gastroenterology and Hepatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
J Immunother Cancer ; 9(8)2021 08.
Article en En | MEDLINE | ID: mdl-34341130
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Receptor de Muerte Celular Programada 1 / Aparato de Golgi / Inmunoterapia / Proteínas de Neoplasias Tipo de estudio: Risk_factors_studies Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Receptor de Muerte Celular Programada 1 / Aparato de Golgi / Inmunoterapia / Proteínas de Neoplasias Tipo de estudio: Risk_factors_studies Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article